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Because of the low sensitivity of sputum smears and the delay in cultures (2–4 weeks for a result),
a variety of new technologies have been developed for the more rapid and sensitive detection of PTB.
This article address the new diagnostic techniques for Tuberculosis. These techniques help in early
daignosis of tuberculosis.
 2009 Elsevier Ltd. All rights reserved.Educational aims
 To outline new diagnostic techniques for diagnosis of TB
infection
 To outline new diagnostic techniques TB Disease.1. Introduction
Because of the low sensitivity of sputum smears and the delay in
cultures (2–4 weeks for a result), a variety of new technologies have
been developed for the more rapid and sensitive detection of PTB.
At present, the use of these techniques is the subject of much
debate.
New diagnostic techniques in can be broadly divided into two
parts
1) Techniques for diagnosis of TB infection.
2) Techniques for the diagnosis of TB disease.2. Techniques for diagnosis of TB infection
2.1. Interferon-assays(IFN-g)
This test measures the amount of interferon-g; in the blood.
On stimulation by mycobacterial peptides the amount of IFN-
gamma increases in the blood. This test is different from
conventional BCG test as it uses proteins known as ESAT-6 andAll rights reserved.CFP-10, which are present in Mycobacterium tuberculosis but
absent from all BCG strains and from most non-tuberculosis
mycobacteria. It is intended for use as a diagnostic aid for
M. tuberculosis infection, including both tuberculosis disease and
latent tuberculosis infection (LTBI). The advantages of, Inter-
feron-assays compared with the tuberculin skin test, are that
results can be obtained after a single patient visit, and that,
because it is a blood test which is performed in a qualiﬁed
laboratory, the variability associated with skin test reading can
be eliminated.
An additional advantage of this newer generation blood test is
that the test is not affected by past BCG vaccination, and will
eliminate the unnecessary treatment of patients with BCG-related
false positive results. Furthermore, the Interferon-assays does not
affect the result of future Interferon-assays tests (i.e. no ‘‘boosting,’’
as with the TST).
Various interferon- assays available are-
 Enzyme linked immunosorbent assay (ELISA) e.g QuantiFERON
TB and QuantiFERON TB Gold assay.
 Enzyme linked immunospot – ELISPOT (e.g T SPOT TB assay).3. Techniques for the diagnosis of TB disease
3.1. Direct methods for detection of Mycobacteria or its products
(a) Microscopy – Advancement had been made to increase the
sensitivity of sputum microscopy. A new method to
improve culture and acid-fast staining of mycobacteria is
introduced. This new method utilized N,N-dimethyl-N-(n-
octadecyl)-N-(3-carboxypropyl) ammonium inner salt, also
known as C18-carboxypropylbetaine (Zwitterionic
detergent).1
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conventional media is that it takes at least 4 weeks. Various
rapid methods are now available, these include
(i) Microcolony detection on solid media
(ii) Septi-check AFB method
(iii) Microscopic observation of in broth culture (MODS)
(iv) BACTEC 460 radiometric culture system
(v) BACTEC MGIT 960 system
(vi) MB/Bact system
(vii) ESP II culture system
(i) Microcolony detection on solid media
This is a better technique for culturing tubercle bacilli.2 This
technique is less expensive and requires about half the time
needed for conventional culture, however the recovery of
mycobacteria is less efﬁcient.
(ii) Septi-check AFB method
It is biphasic culture systemmade up of a modiﬁedMiddlebrook
7H9 broth with a three-sided paddle containing chocolate, egg
based, and modiﬁed 7H11 solid agar, the bottle is inverted
regularly to inoculate the solid media. The growth is observed
by observing the three-sided paddle.
(iii) Microscopic observation of in broth culture (MODS)
This technique is appropriate for disease endemic high burden
countries. It requires 7H9 broth, oleic acid dextrose catalase
(OADC) and antimicrobial supplement.3
(iv) BACTEC 460 radiometric culture system
Culture media contains 14C-labeled palmitic acid. If present in the
broth, mycobacteria metabolize the 14C-labeled substrates and
release radioactively labeled 14CO2 in the atmosphere, which
collects above the broth in the bottle. The instrument withdraws
this CO2-containing atmosphere and measures the amount of
radioactivity present. Bottles that yield a radioactive index, called
agrowth index, greater thanorequal to10 are consideredpositive.
(v) BACTEC MGIT 960 system
Culture tube contains Middlebrook 7H9 broth and a ﬂuorescent
compound embedded in a silicone sensor. Growth is detected
visually using an ultraviolet light. Oxygen (O2) diminishes the
ﬂuorescent output of the sensor; therefore, O2 consumption by
organism present in the medium are detected as an increase in
ﬂuorescence.
(vi) MB/Bact system
This system is based on the colorimetric detection of CO2. It had
slightly longer time for detection of growth as compared to
BACTEC 460 system.4
(vii) ESP II culture system
Organism are cultured in a modiﬁed Middlebrooks 7H9 broth
with enrichment and a cellulose sponge to increase the culture’s
surface area. The instrument detects growth by monitoring
pressure changes that occurs as a result of O2 consumption or
gas production by the organism as they grow. It should be used
in combination with solid media.5
3.2. Identiﬁcation of Mycobacterial species
Earlier biochemical’s were used for identiﬁcation of mycobac-
terial species,6 however these were time consuming. To over come
this various methods have come up, these are –a) Lipid proﬁles – Since mycobacteria have characteristic lipid
proﬁle, these can be analyzed by high-pressure liquid
chromatography.7
b) SDS-PAGE – The sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (SDS-PAGE) proﬁles of an easily and rapidly
prepared soluble protein fractionwereused in conjunctionwith
conventional techniques to identify different strains of Myco-
bacterium tuberculosis, Mycobacterium bovis, Mycobacterium.
bovis BCG, Mycobacterium africanum, Mycobacterium avium,
Mycobacterium kansasii, Mycobacterium marinum, Mycobacte-
rium gastri, Mycobacterium simiae and Mycobacterium mal-
moense. With the SDS-PAGE technique, all strains of the M.
tuberculosis complex were recognized as belonging to one
species. By visual analysis of the SDS-PAGE polypeptide proﬁles,
onlyminordifferences betweenstrainsof the samespecieswere
seen and each species show a characteristic polypeptide
proﬁle.8
c) Sherlock Mycobacterial Identiﬁcation System – The Sherlock
Mycobacterial Identiﬁcation System (SMIS; MIDI, Inc.) has been
developed for the rapid, computer-assisted identiﬁcation of
mycobacterial species based on the separation and quantiﬁca-
tion of mycolic acids using HPLC technology.9
d) GenoType assay – The GenoType assay allows for the identiﬁ-
cation of 16 different mycobacterial species that are most
frequently isolated in the clinical laboratory.10 Isolation is
commonly done by PCR ampliﬁcation of the 16S–23S ribosomal
DNA spacer region followed by hybridization of the bio-
tinylated ampliﬁed DNA products with 16 speciﬁc oligonucle-
otide probes.10 The speciﬁc probes are immobilized as parallel
lines on a membrane strip.10
e) PCR restriction enzyme analysis – It identiﬁes 65 kDa hsp gene
and 16s rRNA gene of mycobacteria.
f) DNA chips – Also called DNA-microarrays. These consists of
very large number of evenly spaced spots of DNA ﬁxed to
microscopic slide. Each spot is a unique DNA fragment trans-
ferred by a gridding robot from 96-well plates on to the slides.
DNA extracts from ‘unknown’ isolates yield distinctive patterns
of hybridization on the slide.
4. Molecular methods
(a) Polymerase Chain Reaction – A technique of DNA ampliﬁcation
that uses speciﬁc DNA sequences to serve as marker for the
presence of microorganism, it can even detect a single bacteria.
The commercial PCR assay is based on ampliﬁcation of 584 bp
region of a gene encoding 16sRNA.
Nested PCR – The two sets of primers used for ampliﬁcationwere
derived from the gene sequence encoding the insertion sequence
IS6110 as follows: external primers were derived from position 367
to 392 (50-CCGGCCAGCACGCTAATTAACGGTTC-30) and position 769
to 746 (50-TGTGGCCGGATCAGCGATCGTGGT-30); and internal
primers were derived from position 455 to 472 (50-CTGCACA
CAGCTGACCGA-30) and position 670 to 652 (50-CGTTCGACGGTG
CATCTG-30). The reaction mixture consisted of 10 mM Tris/HCl (pH
8.3), 50 mM KCl, 2 mMMgCl2, 0.15 mM dATP, dGTP, dCTP, 0.45 mM
dUTP, 2 pmol external primers, 75 pmol internal primers, 2 U
AmpliTaq Gold polymerase, and 0.5 U heat labile uracil-N-glyco-
sylase in a total reaction volume of 100 ml. The mixture was ﬁrst
incubated at 37 C for 10 min with uracil-N-glycosylase to destroy
any contaminating amplicons, and then at 94 C for 12 min to
activate the AmpliTaq polymerase, followed by subsequent
temperature cycling at 94 C for 45 s and 72 C for 1.5 min for the
ﬁrst 15 cycles, followed by 94 C for 45 s, 55 C for 45 s, and 72 C
for one min for 45 cycles. Positive and negative controls were
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ination were observed. Ampliﬁed products were electrophoresed
through a 2% agarose gel in Tris borate buffer. Target bands of 21 bp
were visualised by staining with ethidium bromide.
Other modiﬁcation of PCR include – the strand displacement
ampliﬁcation(SDA)
- transcription based ampliﬁcation(TAS)
- self - sustaining sequence replication
Real time PCR – a technique which can detect the target within
30–120 min using PCR. It combines rapid thermocycling with the
ability to detect target by ﬂuorescently labeled probes as the
hybrids are formed, i.e in real time. This technique allows multi-
plexing reactions, quantitation of targets, and online monitoring.
(c) Ligase chain reaction – Ampliﬁcation of probe nucleic acid
rather than target nucelic acid provides a strategy for
enhancing the sensitivity of molecular diagnostic techniques.
By this approach an ampliﬁed probe is the ﬁnal reaction
product to be detected, while the target sequence is neither
ampliﬁed nor incorporated into this product.
(d) Ampliﬁcation of the probe signal – Rather than amplifying either
the target or probe, the signal used to detect hybridization
between the amplicon and probe can be ampliﬁed by
increasing the number of reporter molecules per probe
(e) Sequencing and enzymatic digestion of nucleic acid – This
method is used independently or in association with hybrid-
ization or ampliﬁcation procedures.
5. Serological diagnosis of TB.11
i) Immunochromatographic tests:
- ICT Tuberculosis and
- RAPID TEST TB
ii) Enzyme linked immunosorbent assays:
- TUBERCULOSIS IgA EIA
- PATHOZYME-TB complex,
- PATHOZYME-MYCO IgG,
- PATHOZYME-MYCO IgA, and
- PATHOZYME-MYCO IgM,
i) Immunochromatographic tests
Five highly puriﬁed antigens (includingoneof 38 kDa) secreted by
M.tuberculosisduringactive infectionare immobilized in four lines
on the test strip. The test detects the presence of immunoglobulin
G (IgG) antibodies to these antigens. A total of 30 ml of serum is
added toabluepadand thendiffusesalongthe test strip.Whenthe
test card is closed, anti-human IgG attached to colloidal gold
particles binds to anyboundhuman IgGantibodies, producingone
or more pink lines. The presence of one or more pink lines in the
strip’s test area is considered a positive test result.
The RAPID TEST TB – a one-step colored immunochromato-
graphic assay. It detects antibodies to the recombinant 38-kDa
antigen from M. tuberculosis expressed in and puriﬁed from
Escherichia coli. A total of 100 ml of serum is added to the reaction
tube, and the test strip is placed into the tube, which is then capped.
After 15 min of incubation, the presence of two colored bands is
considered a positive test result.
ii) Enzyme linked immunosorbent assays
TUBERCULOSIS IgA EIA detects IgA antibody to a mycobacterial
Kp90 immuno-cross-reactive antigenic compound (ImCRAC).100 ml of diluted (1:400) serum was distributed in microtiter
wells, and incubated at 37 C in a dark humid environment for
60 min. The wells were subsequently incubated with 100 ml of
peroxidase-labeled anti-human IgA conjugate at 37 C in a dark
humid environment for 60 min. After another wash cycle, 100 ml
of peroxidase substrate, tetramethylbenzidine containing
hydrogen peroxide, was added to the wells. The colorimetric
reaction proceeded in the dark for 30 min at room temperature
(20 to 25 C) until 100 ml of stop agent was added. The absor-
bance values at 450 nmwere recordedwith an automatic reader
system. The ratio of the OD for the unknown serum sample to
the cutoff OD was used to interpret the results.
The PATHOZYME-TB complex test detects serum IgG antibody to
a recombinant 38-kDa antigen from M. tuberculosis expressed in
and puriﬁed from E. coli. This kit is speciﬁc for the diagnosis of
disease due to M. tuberculosis complex. The procedures were
similar to those described for TUBERCULOSIS IgA EIA, except that
the sera were diluted 1:50, the second incubation was for 30 min
rather than 60 min, the ﬁrst and second incubations were not in
a dark humid environment, and the third incubation was in the
dark at 37 C for 15 min. Three standards (with 2, 4, and
16 serounits/ml) were provided for the generation of a semi-
logarithmic reference curve. Because the sera were diluted 1:50,
the units extrapolated from the reference curve were multiplied by
50 to obtain serounits for result interpretation.
The individual PATHOZYME-MYCO lgG, lgA, and lgM assay. The
three assays measure the levels in serum of IgG, IgA, and IgM anti-
bodies, respectively, to twoantigens; lipoarabinomannan (LAM) and
recombinant 38-kDa antigen. These kits detect infection due to
mycobacterium species. The procedures were identical to those
described for PATHOZYME-TB complex except that the sera were
diluted 1:100 rather than 1:50 and all three incubations were at
room temperature. For the IgG and IgA assays three standards (with
2, 4, and 16 serounits/ml) were provided for generation of a semi-
logarithmic reference curve. Because the sera were diluted 1:100,
the units extrapolated from the reference curve were multiplied by
100 to obtain serounits for result interpretation. For the IgM assay,
low- and high-positive control sera were provided. The OD of the
low-positive control was used for the interpretation of the results.6. Conclusion
New diagnostic techniques currently available are no more
sensitive (and a great deal more expensive) than properly per-
formed sputum smear and culture examination. Their usefulness in
high prevalence countries, especially where there is a high preva-
lence of HIV co-infection, has not yet been established.6.1. Clinical focus
i) Interferon g assay test is not affected by past BCG vaccination,
andwill eliminate the unnecessary treatment of patients with
BCG-related false positive results.
ii) The Interferon-g assays does not affect the result of future
Interferon-assays tests (i.e. no ‘‘boosting,’’ as with the TST).
iii )Molecular methods have sensitivity greater than smear
examination, but less than culture. False positives and false
negatives occur, Cannot differentiate between live and dead
bacilli. Very expensive test.
iv) Serological tests have not been adequately evaluated in high
prevalence TB settings, false negative results are common in
HIV infected persons, and antibody tests cannot distinguish
between active TB and latent infection.
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Answer the following questions: true/false
1. The peptides used in the interferon –gamma assay test mimic
proteins is ESAT-6, CFP-10.
2. The interferon – gamma assay test is affected by past BCG
vaccination.
3. Culture media for BACTEC – 460 contains Palmitic acid.
4. In ESP II culture system, the instrument detects pressure
changes that occurs a result of O2 consumption.
5. PCR can differentiate between live and dead bacilli.References
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